Eli Lilly and Company (LLY)

Index:

S&P 100

$ 878.45
   
  • Change Today:
    $-4.88
  • 52 Week High: $884.61
  • 52 Week Low: $434.70
  • Currency: US Dollars
  • Shares Issued: 949.78m
  • Volume: 2,023,264
  • Market Cap: $834,335m
  • RiskGrade: 179

Latest ShareCast News

Roche sees positive results from weight-loss trials

By Abigail Townsend

Date: Thursday 16 May 2024

(Sharecast News) - Roche reported positive trial results for its experimental weight loss treatment on Thursday, sending shares in the Swiss drugs group higher.

Eli Lilly hikes sales guidance by $2bn, shares jump

By Benjamin Chiou

Date: Tuesday 30 Apr 2024

(Sharecast News) - Shares in Eli Lilly jumped on Wall Street on Tuesday after the American pharma giant beat quarterly profit forecasts and hiked its full-year sales guidance by $2bn, helped by surging demand for its weight-loss drug Zepbound.

Eli Lilly weight-loss drug 'significantly' reduces sleep apnoea

By Abigail Townsend

Date: Wednesday 17 Apr 2024

(Sharecast News) - Eli Lily's weight-loss drug tirzepatide has been shown to "significantly" reduce sleep apnoea severity, the US drugs giant said on Wednesday.

Eli Lilly to buy Point Biopharma in $1.4bn deal 03-Oct-2023 ShareCast
Eli Lilly hikes guidance despite first-quarter e... 27-Apr-2023 ShareCast
Eli Lilly to buy genetic medicine developer Akou... 18-Oct-2022 ShareCast
Eli Lilly misses Q3 estimates, but sales top exp... 26-Oct-2021 ShareCast
Eli Lilly posts slightly weaker than expected Q2... 03-Aug-2021 ShareCast
Eli Lilly buys Protomer Technologies in $1bn deal 14-Jul-2021 ShareCast
Eli Lilly Covid-19 therapy works against new vir... 10-Mar-2021 ShareCast
Eli Lilly therapy shown to reduce death in Covid... 10-Mar-2021 ShareCast
Eli Lilly gets EUA for new antibody 'cocktail', ... 10-Feb-2021 ShareCast
Regeneron Pharmaceuticals Covid-19 antibodies 10... 26-Jan-2021 ShareCast
Eli Lilly treatment cuts Covid-19 risk by 80% in... 22-Jan-2021 ShareCast
Eli Lilly to buy Prevail Therapeutics; lifts 202... 15-Dec-2020 ShareCast
AbCellera looks to net up to $391m from IPO 07-Dec-2020 ShareCast
FDA grants EUA for Eli Lilly treatment in conjun... 20-Nov-2020 ShareCast
FDA grants emergency use approval for Eli Lilly ... 10-Nov-2020 ShareCast
Lilly partners with US government to fight Covid... 28-Oct-2020 ShareCast
Eli Lilly falls short of Q3 EPS forecasts 27-Oct-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

LLY Market Data

Currency US Dollars
Share Price $ 878.45
Change Today $ -4.88
% Change -0.55 %
52 Week High $884.61
52 Week Low $434.70
Volume 2,023,264
Shares Issued 949.78m
Market Cap $834,335m
RiskGrade 179

What The Brokers Say

Strong Buy 9
Buy 12
Neutral 6
Sell 0
Strong Sell 0
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 14-Jun-2024

Time Volume / Share Price
16:00 303,019 @ $878.45
15:59 440 @ $878.90
15:59 340 @ $878.90
15:59 788 @ $879.00
15:59 104 @ $879.00

Top of Page